Acute toluene intoxication--clinical presentation, management and prognosis: a prospective observational study

Background: Toluene is one of the most widely abused inhaled drugs due to its acute neurologic effects including euphoria and subsequent depression. However, dangerous metabolic abnormalities are associated to acute toluene intoxication. It has been previously reported that rhabdomyolysis and acute hepatorenal injury could be hallmarks of the condition, and could constitute risk factors for poor outcomes. The objective was to describe the clinical presentation, to characterize the renal and liver abnormalities, the management and prognosis associated to acute toluene intoxication.

Methods: We prospectively assessed 20 patients that were admitted to a single center's emergency department from September 2012 to June 2014 with clinical and metabolic alterations due to acute toluene intoxication.

Results: The main clinical presentation consisted of weakness associated to severe hypokalemia and acidosis. Renal glomerular injury (proteinuria) is ubiquitous. Biliary tract injury (alkaline phosphatase and gamma-glutamyl transpeptidase elevations) disproportional to hepatocellular injury is common. Rhabdomyolysis occurred in 80% of patients, probably due to hypokalemia and hypophosphatemia. There were three deaths, all female, and all associated with altered mental status, severe acidosis, hypokalemia and acute oliguric renal failure. The cause of death was in all cases due to cardiac rhythm abnormalities.

Conclusion: The hallmarks of acute toluene intoxication are hypokalemic paralysis and metabolic acidosis. Liver injury and rhabdomyolysis are common. On admission, altered mental status, renal failure, severe acidemia and female gender (not significant in our study, but present in all three deaths) could be associated with a poor outcome, and patients with these characteristics should be considered to be treated in an intensive care unit.

Similar articles

Cámara-Lemarroy CR, Gónzalez-Moreno EI, Rodriguez-Gutierrez R, González-González JG. Cámara-Lemarroy CR, et al. Inhal Toxicol. 2012 Jun;24(7):434-8. doi: 10.3109/08958378.2012.684364. Inhal Toxicol. 2012. PMID: 22642292

Latief M, Hassan Z, Shafi O, Abbas F, Farooq S. Latief M, et al. Saudi J Kidney Dis Transpl. 2022 May-Jun;33(3):487-491. doi: 10.4103/1319-2442.385970. Saudi J Kidney Dis Transpl. 2022. PMID: 37843148

Kao KC, Tsai YH, Lin MC, Huang CC, Tsao CY, Chen YC. Kao KC, et al. J Toxicol Clin Toxicol. 2000;38(6):679-81. doi: 10.1081/clt-100102021. J Toxicol Clin Toxicol. 2000. PMID: 11185978

Tormoehlen LM, Tekulve KJ, Nañagas KA. Tormoehlen LM, et al. Clin Toxicol (Phila). 2014 Jun;52(5):479-89. doi: 10.3109/15563650.2014.923904. Clin Toxicol (Phila). 2014. PMID: 24911841 Review.

Baskerville JR, Tichenor GA, Rosen PB. Baskerville JR, et al. Emerg Med J. 2001 Nov;18(6):514-6. doi: 10.1136/emj.18.6.514. Emerg Med J. 2001. PMID: 11696523 Free PMC article. Review.

Cited by

da Silva GMR, Slawka E, Santos ASE, Vianna ADS. da Silva GMR, et al. Rev Bras Med Trab. 2024 Feb 16;21(4):e2021896. doi: 10.47626/1679-4435-2021-896. eCollection 2023 Oct-Dec. Rev Bras Med Trab. 2024. PMID: 39132273 Free PMC article. Review.

Fujikawa H, Ichibayashi R, Sato T, Shimizu M. Fujikawa H, et al. Cureus. 2023 Dec 13;15(12):e50438. doi: 10.7759/cureus.50438. eCollection 2023 Dec. Cureus. 2023. PMID: 38222123 Free PMC article.

Wagner CA, Unwin R, Lopez-Garcia SC, Kleta R, Bockenhauer D, Walsh S. Wagner CA, et al. Nat Rev Nephrol. 2023 Jun;19(6):384-400. doi: 10.1038/s41581-023-00699-9. Epub 2023 Apr 4. Nat Rev Nephrol. 2023. PMID: 37016093 Review.

Wathanavasin W, Banjongjit A, Katavetin P. Wathanavasin W, et al. J Nephrol. 2023 Mar;36(2):341-345. doi: 10.1007/s40620-022-01500-z. Epub 2022 Nov 3. J Nephrol. 2023. PMID: 36327039 No abstract available.

Hamid OIA, Domouky AM, El-Fakharany YM. Hamid OIA, et al. Sci Rep. 2022 Jun 2;12(1):9194. doi: 10.1038/s41598-022-13173-6. Sci Rep. 2022. PMID: 35654991 Free PMC article.

References

    1. Abi-Gerges N, Philp K, Pollard C, Wakefield I, Hammond TG, Valentin JP. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes. Fundam Clin Pharmacol. 2004;18:139–51. doi: 10.1111/j.1472-8206.2004.00230.x. - DOI - PubMed
    1. Ahlawat SK, Sachdev A. Hypokalaemic paralysis. Postgrad Med J. 1999;75(882):193. doi: 10.1136/pgmj.75.882.193. - DOI - PMC - PubMed
    1. Alkaabi JM, Mushtaq A, Al-Maskari FN, Moussa NA, Gariballa S. Hypokalemic periodic paralysis: a case series, review of the literature and update of management.Eur. J Emerg Med. 2010;17(1):45–7. - PubMed
    1. Alper AT, Akyol A, Hasdemir H, Nurkalem Z, Güler O, Güvenç TS, Erdinler I, Cakmak N, Eksik A, Gürkan K. Glue (toluene) abuse: increased QT dispersion and relation with unexplained syncope. Inhal Toxicol. 2008;20(1):37–41. doi: 10.1080/08958370701758304. - DOI - PubMed
    1. ATSDR (Agency for Toxic Substances and Disease Registry) Toxicological profile for toluene. Atlanta, GA: ATSDR; 2000. - PubMed